Analyst Ratings for Theravance Biopharma (TBPH)
TBPH Rating Summary
TBPH Price Target Summary
- Highest: $21.00 (BTIG)
- Lowest: $10.00 (TD Cowen)
- Average: $15.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$15.50 (+69.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
Avg. $ Target:
$15.50 (+69.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/12/2024 | BTIG | Julian Harrison | New Coverage | Buy (N/A) |
21.00 (N/A) |
8.93 (9.14) |
2.35% | Details |
| 5/23/2022 | Leerink Partners » Updated 11/17/2022 |
David Risinger | New Coverage | Outperform (N/A) |
14.00 (12.00) |
8.85 (9.14) |
3.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
